MedPath

Which maintenance intravenous fluid therapy is best in children?

Not Applicable
Completed
Conditions
Health Condition 1: Z750- Medical services not available inhome
Registration Number
CTRI/2021/08/035924
Lead Sponsor
AIIMS Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
142
Inclusion Criteria

Children who are planned to receive more than 50% of total calculated maintenance intravenous fluids.

Exclusion Criteria

Any condition which requires change of maintenance fluids

Known case of CKD/ congenital or acquired severe liver disease/ Diabetes insipidus and Diabetes mellitus.

Conditions / Procedural fluid therapy in which intravenous fluids were expected to be given for shorter duration than 6 h example any planned procedure like C.T/MRI Scans

Conditions causing changes in chloride levels example: Barter syndrome, Congenital Adrenal Hyperplasia etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To calculate the mean difference of hyperchloremia in children receiving 5% Dextrose in Ringerâ??s Lactate versus 5% Dextrose Normal Saline at 24 and 48hrs after start of fluids.Timepoint: To calculate the mean difference of hyperchloremia in children receiving 5% Dextrose in Ringerâ??s Lactate versus 5% Dextrose Normal Saline at 24 and 48hrs after start of fluids.
Secondary Outcome Measures
NameTimeMethod
Proportion of children developing Acute Kidney Injury as defined below in both groupsTimepoint: 24 and 48 hours;Proportion of children developing dyselectrolytemia (hyperchloremia, hypochloremia, <br/ ><br> hypernatremia, hyponatremia, hyperkalemia and hypokalemia) as defined below in both groupsTimepoint: 24 and 48 hours;Proportion of children developing hyperchloremic metabolic acidosis as defined below in both groupsTimepoint: 24 and 48 hours;To estimate all-cause mortality in both groups.Timepoint: Any time in hospital
© Copyright 2025. All Rights Reserved by MedPath